Classification ![]() |
|
| Compound class | Endogenous peptide in human, mouse or rat |
| Approved drug? | Yes (source: FDA (1976)) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 239 | somatropin |
Gene/Precursor ![]() |
||||||||||
|
Synonyms ![]() |
| Saizen® |
| somatotropin |
Database Links ![]() |
|
| CAS Registry No. | 12629-01-5 (source: Scifinder) |
| DrugBank Ligand | DB00052 (Hs) |
| Ensembl Gene | ENSG00000189162 (Hs) |
| Search PubMed clinical trials | somatropin |
| Search PubMed titles | somatropin |
| Search PubMed titles/abstracts | somatropin |
| UniProtKB | P01241 (Hs) |
| Wikipedia | Growth_hormone_1 |
| Comments |
| Human growth hormone 1 (somatropin) produced by recombinant technology is an approved drug with the INN somatropin. This has identical 191-amino acid sequence to the endogenous hormone. Biosimilar drug: The EMA approved the biosimilar named Omnitrope (Sandoz GmbH) in 2006. |